Optimind Pharma (XCNQ:OMND) ROE % Adjusted to Book Value : 0.00% (As of Nov. 2024)

View and export this data going back to 2022. Start your Free Trial

What is Optimind Pharma ROE % Adjusted to Book Value?

Optimind Pharma's ROE % for the quarter that ended in Nov. 2024 was 0.00%. Optimind Pharma's PB Ratio for the quarter that ended in Nov. 2024 was N/A. Optimind Pharma's ROE % Adjusted to Book Value for the quarter that ended in Nov. 2024 was N/A.

Optimind Pharma ROE % Adjusted to Book Value Historical Data

The historical data trend for Optimind Pharma's ROE % Adjusted to Book Value can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Optimind Pharma ROE % Adjusted to Book Value Chart

Optimind Pharma Annual Data

Trend

Feb22

Feb23

Feb24

ROE % Adjusted to Book Value

-29.30

Optimind Pharma Quarterly Data
	Jun21	May22	Aug22	Nov22	Feb23	May23	Aug23	Nov23	Feb24	May24	Aug24	Nov24
ROE % Adjusted to Book Value	Get a 7-Day Free Trial							-24.91	-	-	-	-

Competitive Comparison of Optimind Pharma's ROE % Adjusted to Book Value

For the Drug Manufacturers - Specialty & Generic subindustry, Optimind Pharma's ROE % Adjusted to Book Value, along with its competitors' market caps and ROE % Adjusted to Book Value data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Optimind Pharma's ROE % Adjusted to Book Value Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Optimind Pharma's ROE % Adjusted to Book Value distribution charts can be found below:

* The bar in red indicates where Optimind Pharma's ROE % Adjusted to Book Value falls into.

Optimind Pharma ROE % Adjusted to Book Value Calculation

Optimind Pharma's ROE % Adjusted to Book Value for the fiscal year that ended in Feb. 2024 is calculated as

ROE % Adjusted to Book Value	=	ROE %	/	PB Ratio
	=	-547.16%	/	N/A
	=	N/A

Optimind Pharma's ROE % Adjusted to Book Value for the quarter that ended in Nov. 2024 is calculated as

ROE % Adjusted to Book Value	=	ROE %	/	PB Ratio
	=	0.00%	/	N/A
	=	N/A

Optimind Pharma ROE % Adjusted to Book Value Related Terms

Thank you for viewing the detailed overview of Optimind Pharma's ROE % Adjusted to Book Value provided by GuruFocus.com. Please click on the following links to see related term pages.

Optimind Pharma Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Optimind Pharma Corp (XCNQ:OMND) » Definitions » ROE % Adjusted to Book Value

Comparable Companies

Traded in Other Exchanges

N/A

Address

77 King Street West, Suite 3000, TD Centre, North Tower, PO Box 95, Toronto, ON, CAN, M5K 1G8

Website

https://www.optimindpharma.com

Optimind Pharma Corp is an emerging provider of psychedelic therapies for the masses. It helps people suffering from PTSD, Anxiety, Depression, and other mental illnesses and disabilities by providing ketamine-assisted-treatment and other psychedelic-enhanced-psychotherapy modalities. It is also partnered with developers of psilocybin-associated treatments and products to further expand its treatment and program offerings.

Optimind Pharma Headlines

No Headlines